Santiago Munné developed the first Preimplantation Genetic Testing of Aneuploidy (PGT-A) (1993), now used in over 50% of US cycles, and PGT-SR. Published >260 peer-reviewed articles and received 8 SART and ASRM prize papers, the 12 ASRM Star Award. In 2024 their paper on automated ICSI obtained the Robert G Edwards prize paper award from RBMO. He founded Reprogenetics (PGT), Recombine (Carrier screening), MedAnswers (tele-Medicine), Phosphorus (genomics), Overture Life (IVF automation) and Homu Health Ventures (incubator focused on reproductive medicine). Currently he is Scientific Director of Progenesis, Chief Innovation Officer at Overture Life, president of Homu health Ventures. He also serves in the scientific board of GenEmbryomics, Sama and Butterfly.